Free drug trial offers relief for rare swelling disorder
Disease control
Completed
This study tested the safety and effectiveness of an already-approved drug, icatibant injection, for treating sudden, severe swelling attacks caused by a condition called bradykinin-induced angioedema. It involved 5 adult patients in Taiwan who could not get the drug through thei…
Phase: PHASE4 • Sponsor: Nang Kuang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC